Oxaliplatin has been strongly linked to the occurrence of chemotherapy-induced thrombocytopenia (CIT)ally (58), immune thrombocytopenia (ITP) has been reported as a secondary effect of PD-1/PD-L1 inhibitor therapies (59). This evidence concerns the gene CD274 and Thrombocytopenia.